"南光" 五號注射液

국가: 대만

언어: 중국어

출처: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Download 환자 정보 전단 (PIL)
11-06-2020
Download 공공 평가 보고서 (PAR)
28-03-2020

유효 성분:

SODIUM CHLORIDE;;POTASSIUM ACETATE;;SODIUM ACETATE ANHYDROUS;;MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O);;POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE);;DEXTROSE MONOHYDRATE

제공처:

南光化學製藥股份有限公司 臺南市新化區全興里中山路1001號、1001-1號 (69275313)

ATC 코드:

B05BB02

약제 형태:

注射劑

구성:

POTASSIUM ACETATE (4008000100) MG; SODIUM ACETATE ANHYDROUS (4008000650) MG; MAGNESIUM CHLORIDE HEXAHYDRATE (EQ TO MAGNESIUM CHLORIDE 6H2O) (4012001550) MG; SODIUM CHLORIDE (4012002100) MG; DEXTROSE MONOHYDRATE (4020000570) MG; POTASSIUM PHOSPHATE MONOBASIC(EQ TO POTASSIUM BIPHOSPHATE)(EQ TO POTASSIUM DIHYDROGEN PHOSPHATE) (5612001910) MG

패키지 단위:

瓶裝;;袋裝

수업:

製 劑

처방전 유형:

限由醫師使用

Manufactured by:

南光化學製藥股份有限公司 台南市新化區全興里中山路1001號 TW

치료 영역:

electrolytes with carbohydrates

치료 징후:

手術前後及未能進食之病人之水份、電解質、熱能補充或維持液

제품 요약:

有效日期: 2028/12/23; 英文品名: NAKO NO.5 INJECTION "N.K."

승인 날짜:

1986-12-23